SALT LAKE CITY, Feb. 01, 2024 Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select.
30.01.2024 - SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of .
SALT LAKE CITY, Jan. 30, 2024 Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced the appointment of George Daneker Jr., MD, as President and Chief.